Clinical Trial

The Effectiveness of E-health Intervention in Improving Mental Health Outcomes Among Breast Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated September 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
Study Purpose: The study aims to assess how effective e-health interventions are at improving mental health help-seeking intentions and behaviours among breast cancer patients. Intervention: E-health interventions will be utilized to encourage patients to seek mental health support. These interventions are designed to be accessible and convenient, offering support and information through digital platforms. Participants: The study will involve breast cancer patients between the ages of 18 and 65. Key Objectives: Primary Goal: To measure any changes in patients' intentions and actions to seek mental health support before and after using e-health interventions. Secondary Goals: To explore how these interventions impact mental health literacy, reduce self-stigma, and identify barriers and facilitators to seeking help. Comparison: The study will compare outcomes for patients using e-health tools against those receiving traditional care without digital interventions. Expected Outcomes: Researchers anticipate that e-health interventions will improve mental health help-seeking behaviours, enhance understanding of mental health issues, and reduce the stigma associated with seeking support. Significance: This study could demonstrate the potential of digital health tools to support mental well-being among breast cancer patients, providing new ways to access care and overcome traditional barriers to seeking mental health support.
Trial Details
NCT Number NCT06566937
Lead Sponsor National University of Malaysia
Conditions Breast Cancer, Breast Neoplasms, Depression, Anxiety, Distress, Emotional
Enrollment 114 participants
Start Date 2024-08-09
Primary Completion 2024-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-22